Autism is a complex neurodevelopmental disorder that affects social interaction, communication, and behavior. It is estimated that 1 in 59 children is diagnosed with autism spectrum disorder (ASD) in the United States. While there MMC is no known cure for autism, there are various treatments available to help manage symptoms and improve quality of life for individuals with autism. One promising avenue of research for the treatment of autism is the use of stem cells. Stem cells are unique cells in the body that have the ability to develop into different types of cells and tissues. They have the potential to repair damaged tissues, regenerate cells, and modulate the immune system. Stem cell therapy has shown promising results in various neurological disorders, including autism. Stem cell therapy for autism involves the use of either mesenchymal stem cells (MSCs) or umbilical cord blood stem cells. MSCs are adult stem cells that can differentiate into a variety of cell types, including neurons. Umbilical cord blood stem cells are obtained from the blood of the umbilical cord after a baby is born and have the ability to differentiate into different types of cells as well. Research studies have shown that stem cell therapy can improve symptoms of autism by promoting neuroregeneration, reducing inflammation, and modulating the immune response. Stem cells have the potential to repair damaged neural circuits, enhance synaptic connectivity, and improve cognitive function in individuals with autism. They can also help regulate the levels of neurotransmitters in the brain, such as serotonin and dopamine, which are often imbalanced in individuals with autism. Clinical trials evaluating the safety and efficacy of stem cell therapy for autism are ongoing. Preliminary results have shown that stem cell therapy is safe and well-tolerated in individuals with autism. Some studies have reported improvements in social interaction, communication skills, and behavior in children who received stem cell therapy. It is important to note that stem cell therapy for autism is still considered experimental and is not yet approved by regulatory agencies, such as the Food and Drug Administration (FDA). It is crucial for individuals and families considering stem cell therapy for autism to consult with a healthcare provider and to participate in clinical trials to ensure safety and efficacy. In conclusion, stem cell therapy holds great promise for the treatment of autism. Research studies have shown that stem cells have the potential to improve symptoms of autism by promoting neuroregeneration, reducing inflammation, and modulating the immune response. While more research is needed to fully understand the effects of stem cell therapy on autism, it is an exciting area of research that offers hope for individuals with autism and their families.